Expression of testis specific genes TSGA10, TEX101 and ODF3 in breast cancer

Iranian Red Crescent Medical Journal

Volumn 14, Issue 11, 2012, Pages 730-734

  Dianatpour, Mehdi ^a   Mehdipour, Parvin ^a   Nayernia, Karim ^b   Mobasheri, Maryam Beigom ^a   Ghafouri Fard, Soudeh ^c   Shahram, Savad ^a   Modarressi, Mohammad Hossein ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Gene; ODF3; Testis; TEX101; TSGA10

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROADENOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; ODF3 GENE; ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS; TEX101 GENE; TSGA10 GENE;

EID: 84870194498     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: 10.5812/ircmj.3611     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.
2. Almeida LG, Sakabe NJ, deOliveira AR, Silva MC, Mundstein AS, Cohen T, et al. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res. 2009;37(Database issue):D816-D819.
3. Hofmann O, Caballero OL, Stevenson BJ, Chen YT, Cohen T, Chua R. Genome-wide analysis of cancer/testis gene expression. Proc Natl Acad Sci U S A. 2008;105(51):20422-20427.
4. Karn T, Pusztai L, Ruckhaberle E, Liedtke C, Muller V, Schmidt M, et al. Melanoma antigen family A identifed by the bimodal-ity index defnes a subset of triple negative breast cancers as candidates for immune response augmentation. Eur J Cancer. 2012;48(1):12-23.
5. Adams S, Greeder L, Reich E, Shao Y, Fosina D, Hanson N, et al. Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention? Cancer Immunol Immunother. 2011;60(7):999-1007.
6. Chen YT, Ross DS, Chiu R, Zhou XK, Chen YY, Lee P, et al. Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers. PLoS One. 2011;6(3).
7. Ghafouri-Fard S, Modarressi MH. Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med. 2009;12(4):395-404.
8. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Can-cer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005;5(8):615-625.
9. Zhou JX, Li Y, Chen SX, Deng AM. Expression and prognostic signifcance of cancer-testis antigens (CTA) in intrahepatic chola-giocarcinoma. J Exp Clin Cancer Res. 2011;30(2).
10. Pelletier RM, Byers SW. The blood-testis barrier and Sertoli cell junctions: structural considerations. Microsc Res Tech. 1992;20(1):3-33.
11. Clinical Trials.gov A service of the U.S. National Institutes of Health. 2012 [updated 2012; cited 2012]; Available from: http://www.clinicaltrials.gov.
12. Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 2004;4(1).
13. Curigliano G, Viale G, Ghioni M, Jungbluth AA, Bagnardi V, Sp-agnoli GC. Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol. 2011;22(1):98-103.
14. Lee JH, Jung C, Javadian-Elyaderani P, Schweyer S, Schutte D, Shoukier M, et al. Pathways of proliferation and antiapoptosis driven in breast cancer stem cells by stem cell protein piwil2. Cancer Res. 2010;70(11):4569-4579.
15. Modarressi MH, Cameron J, Taylor KE, Wolfe J. Identifcation and characterisation of a novel gene, TSGA10, expressed in testis. Gene. 2001;262(1-2):249-255.
16. Mobasheri MB, Jahanzad I, Mohagheghi MA, Aarabi M, Farzan S, Modarressi MH. Expression of two testis-specifc genes, TSGA10 and SYCP3, in diferent cancers regarding to their pathological features. Cancer Detect Prev. 2007;31(4):296-302.
17. Ghafouri-Fard S, Abbasi A, Moslehi H, Faramarzi N, Taba Taba Vakili S, Mobasheri MB, et al. Elevated expression levels of testis-specifc genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features. Br J Der-matol. 2010;162(4):772-779.
18. Ghafouri-Fard S, Ousati Ashtiani Z, Sabah Golian B, Hashemi-nasab SM, Modarressi MH. Expression of two testis-specifc genes, SPATA19 and LEMD1, in prostate cancer. Arch Med Res. 2010;41(3):195-200.
19. Hagtvedt T, Aalokken TM, Notthellen J, Kolbenstvedt A, Haye R. [Sinus radiography and low-dose CT in the diagnosis of acute sinusitis.]. Tidsskr Nor Laegeforen. 2003;123(23):3362-3364.